Personal Information
Organización/Lugar de trabajo
San Francisco, California United States
Ocupación
Entrepreneur, Biotech, Drug Discovery and Development, University Teaching Experience
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
http://alquest.us/
Acerca de
• 15+ years in biotech and pharma profession: Research and Development team leader
• Preclinical PK and bioanalytical study administrator: designed preclinical DMPK and bioanalytical protocols implemented by CROs that allowed for “go/no go” decisions within budget
• Early discovery, preclinical and clinical team experience: worked on early discovery and preclinical project teams as well as on programs involving Phase 1 and Phase 2 clinical candidates
• Managed DMPK programs running concurrently in several therapeutic areas: cardiovascular, gastrointestinal, antiviral, and neurological disorders
• Entrepreneurial spirit: identified new potential therapeutic opportunities for...
Etiquetas
cyp2c9
cyp3a4
cyp450s
adducts
mechanism-based inactivation
mass spectrometry
Ver más
Presentaciones
(11)Personal Information
Organización/Lugar de trabajo
San Francisco, California United States
Ocupación
Entrepreneur, Biotech, Drug Discovery and Development, University Teaching Experience
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
http://alquest.us/
Acerca de
• 15+ years in biotech and pharma profession: Research and Development team leader
• Preclinical PK and bioanalytical study administrator: designed preclinical DMPK and bioanalytical protocols implemented by CROs that allowed for “go/no go” decisions within budget
• Early discovery, preclinical and clinical team experience: worked on early discovery and preclinical project teams as well as on programs involving Phase 1 and Phase 2 clinical candidates
• Managed DMPK programs running concurrently in several therapeutic areas: cardiovascular, gastrointestinal, antiviral, and neurological disorders
• Entrepreneurial spirit: identified new potential therapeutic opportunities for...
Etiquetas
cyp2c9
cyp3a4
cyp450s
adducts
mechanism-based inactivation
mass spectrometry
Ver más